Literature DB >> 12873764

The HIV Env-mediated fusion reaction.

Stephen A Gallo1, Catherine M Finnegan, Mathias Viard, Yossef Raviv, Antony Dimitrov, Satinder S Rawat, Anu Puri, Stewart Durell, Robert Blumenthal.   

Abstract

The current general model of HIV viral entry involves the binding of the trimeric viral envelope glycoprotein gp120/gp41 to cell surface receptor CD4 and chemokine co-receptor CXCR4 or CCR5, which triggers conformational changes in the envelope proteins. Gp120 then dissociates from gp41, allowing for the fusion peptide to be inserted into the target membrane and the pre-hairpin configuration of the ectodomain to form. The C-terminal heptad repeat region and the leucine/isoleucine zipper region then form the thermostable six-helix coiled-coil, which drives the membrane merger and eventual fusion. This model needs updating, as there has been a wealth of data produced in the last few years concerning HIV entry, including target cell dependencies, fusion kinetic data, and conformational intermediates. A more complete model must include the involvement of membrane microdomains, actin polymerization, glycosphingolipids, and possibly CD4 and chemokine signaling in entry. In addition, kinetic experiments involving the addition of fusion inhibitors have revealed some of the rate-limiting steps in this process, adding a temporal component to the model. A review of these data that may require an updated version of the original model is presented here.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12873764     DOI: 10.1016/s0005-2736(03)00161-5

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  182 in total

1.  Three-dimensional structures of soluble CD4-bound states of trimeric simian immunodeficiency virus envelope glycoproteins determined by using cryo-electron tomography.

Authors:  Tommi A White; Alberto Bartesaghi; Mario J Borgnia; M Jason V de la Cruz; Rachna Nandwani; James A Hoxie; Julian W Bess; Jeffrey D Lifson; Jacqueline L S Milne; Sriram Subramaniam
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

2.  Rapid and sensitive detection of retrovirus entry by using a novel luciferase-based content-mixing assay.

Authors:  Andrey A Kolokoltsov; Robert A Davey
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

3.  Membrane-proximal external HIV-1 gp41 motif adapted for destabilizing the highly rigid viral envelope.

Authors:  Beatriz Apellániz; Andrey Ivankin; Shlomo Nir; David Gidalevitz; José L Nieva
Journal:  Biophys J       Date:  2011-11-15       Impact factor: 4.033

4.  Selection with a peptide fusion inhibitor corresponding to the first heptad repeat of HIV-1 gp41 identifies two genetic pathways conferring cross-resistance to peptide fusion inhibitors corresponding to the first and second heptad repeats (HR1 and HR2) of gp41.

Authors:  Wei Wang; Christopher J De Feo; Min Zhuang; Russell Vassell; Carol D Weiss
Journal:  J Virol       Date:  2011-10-12       Impact factor: 5.103

5.  HIV-1 resistance to CCR5 antagonists associated with highly efficient use of CCR5 and altered tropism on primary CD4+ T cells.

Authors:  Jennifer M Pfaff; Craig B Wilen; Jessamina E Harrison; James F Demarest; Benhur Lee; Robert W Doms; John C Tilton
Journal:  J Virol       Date:  2010-04-21       Impact factor: 5.103

6.  Galectin-1-specific inhibitors as a new class of compounds to treat HIV-1 infection.

Authors:  Christian St-Pierre; Michel Ouellet; Denis Giguère; Reiko Ohtake; René Roy; Sachiko Sato; Michel J Tremblay
Journal:  Antimicrob Agents Chemother       Date:  2011-11-07       Impact factor: 5.191

7.  Ceramide, a target for antiretroviral therapy.

Authors:  Catherine M Finnegan; Satinder S Rawat; Anu Puri; Ji Ming Wang; Francis W Ruscetti; Robert Blumenthal
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-15       Impact factor: 11.205

8.  Modular assembly of dimeric HIV fusion inhibitor peptides with enhanced antiviral potency.

Authors:  Junpeng Xiao; Thomas J Tolbert
Journal:  Bioorg Med Chem Lett       Date:  2013-09-20       Impact factor: 2.823

Review 9.  Morphine and rapid disease progression in nonhuman primate model of AIDS: inverse correlation between disease progression and virus evolution.

Authors:  Vanessa Rivera-Amill; Peter S Silverstein; Richard J Noel; Santosh Kumar; Anil Kumar
Journal:  J Neuroimmune Pharmacol       Date:  2009-12-16       Impact factor: 4.147

10.  Pannexin1 hemichannels are critical for HIV infection of human primary CD4+ T lymphocytes.

Authors:  J A Orellana; S Velasquez; D W Williams; J C Sáez; J W Berman; E A Eugenin
Journal:  J Leukoc Biol       Date:  2013-03-01       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.